January 25, 2021 by Jeffrey Woldt
Chain Drug Review's Video Forum, George Rafferty president of corporate partnerships at AmerisourceBergen
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, George Rafferty, president of corporate partnerships at AmerisourceBergen, discusses the drug wholesaler’s innovative go-to-market strategy. The new model aims to provide customers with top-notch day-to-day support, while at the same time fostering more strategic, long-term relationships.
January 18, 2021 by Jeffrey Woldt
AmerisourceBergen, Stefano Pessina, WBA
Issue 01-18-2021, Opinion

Walgreens Boots Alliance and AmerisourceBergen earlier this month took the next but far from final step in their long-standing partnership, when the former agreed to sell the latter most of Alliance Healthcare. Valued at some $6.5 billion, the deal will bring AmerisourceBergen’s pharmaceutical distribution and health care solutions business to 13 countries, mostly in Europe,
January 15, 2021 by Jeffrey Woldt
Alex Gourlay, Walgreens, WBA
Featured Articles, Leading Headlines, Retail News, Technology

DEERFIELD, Ill.— Walgreens Boots Alliance has shifted into high gear since the start of 2021. Building on a foundation that it painstakingly laid in recent years, the company has unleashed a salvo of initiatives designed to buttress its central role in health care and retailing. Following the realignment of its partnership with AmerisourceBergen — a
January 11, 2021 by Jeffrey Woldt
Kevin Holt chief executive officer of Ahold USA, Video Forum
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, Kevin Holt, chief executive officer of Ahold Delhaize USA, talks about significant changes under way at the company. Major investments in existing stores, the enhancement of omnichannel capabilities, and the shift to self-distribution are among the subjects addressed.
January 7, 2021 by Jeffrey Woldt
AmerisourceBerge, Stefano Pessina, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy

DEERFIELD, Ill. — Walgreens Boots Alliance and AmerisourceBergen yesterday took the next but far from final step in their long-standing partnership, when the former agreed to sell the latter most of Alliance Healthcare. Valued at some $6.5 billion, the deal will bring AmerisourceBergen’s pharmaceutical distribution and health care solutions business to 13 countries, mostly in
January 5, 2021 by Jeffrey Woldt
Heyward Donigan, Rite Aid
Featured Articles, Leading Headlines, Retail News

CAMP HILL, Pa. — When Heyward Donigan was chosen to lead Rite Aid Corp. in the summer of 2019, she was tasked with restoring an iconic brand that had lost some of its luster. After devoting the first months on the job to shoring up the company’s finances — which still suffer from a large
January 4, 2021 by Jeffrey Woldt
CVS Health, George Coleman, Video Forum
Featured Articles, Leading Headlines, Videos

George Coleman, senior vice president of merchandising at CVS Health, tells this week’s Video Forum about the company’s evolving strategy at a turning point in its history. Coleman, who has just been named Merchant of the Year by Chain Drug Review, comments on the transition in leadership under way at CVS Health, the company’s omnichannel
January 4, 2021 by Jeffrey Woldt
chain drug industry, COVID-19
Issue 01-04-2021, Opinion

When industry observers look back at a given year, all too often they resort to hyperbole, making shaky claims about the long-term significance of events. The year just ended eliminated that pitfall, at least temporarily: 2020 crystallized several issues — the nation’s deep political divide, the quest for racial justice and the need to act
December 28, 2020 by Jeffrey Woldt
Council for Responsible Nutrition, Steve Mister, Video Forum
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, Steve Mister, president and chief executive officer of the Council for Responsible Nutrition, discusses recent developments in the dynamic vitamin and nutritional supplements category. The topics he speaks to include the performance of the business during the COVID-19 pandemic, CRN’s response to the American Medical Association’s call for greater
December 14, 2020 by Jeffrey Woldt
Chain Drug Review's Video Forum, Nicholas Hall, Nicholas Hall Group of Cos.
Featured Articles, Leading Headlines, Videos

Nicholas Hall is one of the world’s leading experts on consumer health care. In this week’s Video Forum, Hall, executive chairman and creative solutions director at the Nicholas Hall Group of Cos., analyzes the trends shaping the O-T-C business. The impact of e-commerce, sources of innovation, and emerging growth categories are among the topics
December 7, 2020 by Jeffrey Woldt
Association for Accessible Medicines, Dan Leonard, Video Forum
Featured Articles, Leading Headlines, Videos

Dan Leonard, longtime leader of the National Pharmaceutical Council who became CEO of the Association for Accessible Medicines in September, discusses the impact of generic medications on health care, and the challenges and opportunities facing the industry. Among the issues addressed are generics’ role in treating COVID-19 patients, the emergence of biosimilars, and the
December 7, 2020 by Jeffrey Woldt
drug prices
Issue 12-07-2020, Opinion

The Trump administration’s 11th hour attempt to bring down high prescription drug costs succeeded in drawing swift condemnation from health care stakeholders who frequently find themselves at odds. The finalization last month of two rules intended to ease the financial burden on patients — one of which aims to establish a direct connection between what
November 30, 2020 by Jeffrey Woldt
Albertsons Cos., Vivek Sankaran
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, Vivek Sankaran, president and CEO of Albertsons Cos., talks about the need to remain nimble and flexible as consumer behavior changes, the company’s response to COVID-19, Albertsons’ growth strategy, and more.
November 23, 2020 by Jeffrey Woldt
Pharmacy Roundtable, ScriptPro
Featured Articles, Leading Headlines, Videos

Key leaders in community pharmacy recently assembled for a roundtable sponsored by Chain Drug Review to discuss the profession’s impact on health care during the COVID-19 outbreak and beyond. In these highlights from the meeting, panelists from the retailing, pharmaceutical manufacturing and technology sides of the business address the industry’s response to the pandemic, the